| 朱显钟,李金雨,于忠英,林伟鹏,陈家财.经尿道等离子前列腺剜除术与经尿道前列腺电切术治疗良性前列腺增生症的临床疗效对比研究[J].,2022,(12):2280-2283 |
| 经尿道等离子前列腺剜除术与经尿道前列腺电切术治疗良性前列腺增生症的临床疗效对比研究 |
| Comparative Study on Clinical Efficacy of Transurethral Plasma Enucleation of Prostate and Transurethral Resection of Prostate in the Treatment of Benign Prostatic Hyperplasia |
| 投稿时间：2021-11-25 修订日期：2021-12-21 |
| DOI：10.13241/j.cnki.pmb.2022.12.016 |
| 中文关键词: 经尿道等离子前列腺剜除术 经尿道前列腺电切术 良性前列腺增生症 疗效 并发症 |
| 英文关键词: Transurethral plasma enucleation of prostate Transurethral resection of prostate Benign prostatic hyperplasia Curative effect Complications |
| 基金项目:福建省科技计划项目（2017D0010） |
|
| 摘要点击次数: 778 |
| 全文下载次数: 385 |
| 中文摘要: |
| 摘要 目的：对比经尿道等离子前列腺剜除术（TUKEP）与经尿道前列腺电切术（TURP）治疗良性前列腺增生症（BPH）的临床疗效。方法：回顾性分析我院2018年1月1日至2021年3月17日期间收治的200例BPH患者的临床资料。根据手术方式的不同将患者分为A组（n=83）和B组（n=117），A组手术方式为TURP，B组手术方式为TUKEP，比较两组围术期指标，随访6个月，对比两组性功能、尿流动力学变化及并发症发生情况。结果：B组手术时间、术中出血量、尿管留置时间、住院时间、术后冲洗时间短于A组（P<0.05）。术后6个月，两组患者的最大尿流速（Qmax）、膀胱顺应性（BC）升高，剩余尿量（PVR）降低（P<0.05），且B组患者的Qmax、BC高于A组，PVR低于A组（P<0.05）。术后6个月，两组患者的勃起功能评分表（IIEF-5）、射精功能评分表（CIPE-5）评分降低（P<0.05），但B组、A组IIEF-5、CIPE-5评分组间对比无明显统计学差异（P>0.05）。B组的并发症发生率小于A组（P<0.05）。结论：TUKEP、TURP治疗BPH，疗效相当，TUKEP在缩短手术时间、尿管留置时间、术后冲洗时间、住院时间，降低术中出血量，减少并发症发生率，改善尿流动力学方面更有优势。 |
| 英文摘要: |
| ABSTRACT Objective: To compare the clinical efficacy of transurethral plasma enucleation of the prostate (TUKEP) and transurethral resection of the prostate (TURP) in the treatment of benign prostatic hyperplasia (BPH). Methods: The clinical data of 200 patients with BPH who were treated in our hospital from January 1, 2018 to March 17, 2021 were analyzed retrospectively. According to the different operation methods, the patients were divided into group A (n=83) and group B (n=117). Group A was operated by TURP, group B was operated by TUKEP. The perioperative indexes of the two groups were compared, followed up for 6 months, the changes of sexual function, urodynamics and complications were compared between the two groups. Results: The operation time, intraoperative bleeding, urinary catheter retention time, hospital stay and postoperative flushing time in group B were shorter than those in group A (P<0.05). 6 months after operation, the maximum urinary flow velocity (Qmax) and bladder compliance (BC) in two groups were increased, while the residual urine volume (PVR) was decreased (P<0.05), and Qmax and BC in group B were higher than those in group A, and PVR was lower than that in group A (P<0.05). 6 months after operation, the scores of erectile function Rating Scale (IIEF-5) and ejaculation function rating Scale (CIPE-5) in two groups decreased (P<0.05), but there were no significant differences in IIEF-5 and CIPE-5 between group B and Group A (P>0.05). The complication rate in group B was lower than that in group A (P<0.05). Conclusion: TUKEP and TURP are equally effective in the treatment of BPH, TUKEP has more advantages in shortening the operation time, urinary catheter retention time, postoperative flushing time, hospital stay, reducing intraoperative bleeding, reducing the incidence of complications and improving urinary flow dynamics. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
